F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works

Posted on AllSides June 7th, 2021
From The Left

The Food and Drug Administration on Monday approved the first new medication for Alzheimer’s disease in nearly two decades, a contentious decision, made despite opposition from the agency’s independent advisory committee and some Alzheimer’s experts who said there was not enough evidence that the drug can help patients.

The drug, aducanumab, which will go by the brand name Aduhelm, is a monthly intravenous infusion intended to slow cognitive decline in people, with mild memory and thinking problems. It is the first approved treatment to attack the disease process of Alzheimer’s instead of just...

Read full story
Some content from this outlet may be limited or behind a paywall.
https://www.nytimes.com/2021/06/07/health/fda-approves-alzheimers-drug.html

More News about Public Health from the Left, Center and Right

From the Left

From the Center

From the Right